HONG KONG, September 17, 2021--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has today announced a strategic distribution partnership with JMS Co. Ltd, a provider of medical devices and pharmaceuticals, in Japan. Under the agreement, JMS Co. Ltd. will distribute Fresenius Medical Care’s innovative home dialysis therapies in the Japanese market, providing patients with a wider range of dialysis choices to suit their lifestyle, e
Fresenius Medical's (FMS) second-quarter earnings benefit from strong performance across the regions, EMEA, Asia Pacific and Latin America.
DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Half Year Results30.07.2021 / 07:03 The issuer is solely responsible for the content of this announcement. As assumed, COVID-19 pandemic continued to impact organic growth in dialysis and downstream businesses Patient excess mortality rates significantly reduced Negative exchange rate effects continue Earnings development impacted by phasing and strong prior-year base, as indicated Financial targets for FY 2021 confirmed FME25 progra